Focal liver necrosis appears early after partial hepatectomy and is dependent on T cells and antigen delivery from the gut

Liver International

Volumn 29, Issue 8, 2009, Pages 1273-1284

  Rudich, Noam ^a   Zamir, Gideon ^a   Pappo, Orit ^a   Shlomai, Zipora ^a   Faroja, Muhamad ^a   Weiss, Ido D ^a   Wald, Hanna ^a   Galun, Eithan ^a   Peled, Amnon ^a   Wald, Ori ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Enterohepatic circulation; Liver regeneration; Necrosis

Indexed keywords

BROXURIDINE; LIPOPOLYSACCHARIDE; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; BLOCKING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CD3+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOCOMPETENCE; LIVER FAILURE; LIVER INJURY; LIVER NECROSIS; LIVER REGENERATION; LIVER TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; NUDE MOUSE; PARTIAL HEPATECTOMY; SCID MOUSE; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ADOPTIVE TRANSFER; ANIMAL; ANTIGEN PRESENTATION; BONE MARROW TRANSPLANTATION; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; GERMFREE ANIMAL; IMMUNOLOGY; INTESTINE; LIVER; LIVER CIRRHOSIS; LIVER RESECTION; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; STOMACH MUCOSA;

ADOPTIVE TRANSFER; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BLOCKING; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; BONE MARROW TRANSPLANTATION; BROMODEOXYURIDINE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GASTRIC MUCOSA; HEPATECTOMY; INTESTINES; LIPOPOLYSACCHARIDES; LIVER; LIVER CIRRHOSIS; LIVER REGENERATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MICE, SCID; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES;

EID: 70350070538     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02048.x     Document Type: Article

References (33)

1. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004; 127: S248-260.
2. Arciero CA, Sigurdson E.R. Liver-directed therapies for patients with primary liver cancer and hepatic metastases. Curr Treat Options Oncol 2006; 7: 399-409.
3. Arciero CA, Sigurdson E.R. Diagnosis and treatment of metastatic disease to the liver. Semin Oncol 2008; 35: 147-59.
4. Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999; 188: 304-9.
5. Dahm F, Georgiev P, Clavien P.A. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transpl 2005; 5: 2605-10.
6. Helling T.S. Liver failure following partial hepatectomy. HPB 2006; 8: 165-74.
7. Makino H, Togo S, Kubota T, et al. A good model of hepatic failure after excessive hepatectomy in mice. J Surg Res 2005; 127: 171-6.
8. Fausto N, Campbell JS, Riehle K.J. Liver regeneration. Hepatology 2006; 43: S45-53.
9. Dong Z,Wei H, Sun R, Tian Z. The roles of innate immune cells in liver injury and regeneration. Cell Mol Immunol 2007; 4: 241-52.
10. Martins PN, Theruvath TP, Neuhaus P. Rodent models of partial hepatectomies. Liver Int 2008; 28: 3-11.
11. Wald O,Weiss ID,Wald H, et al. IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 2006; 176: 4716-29.
12. Fausto N. Liver regeneration: from laboratory to clinic. Liver Transpl 2001; 7: 835-44.
13. Zimmermann A. Regulation of liver regeneration. Nephrol Dial Transpl 2004; 19(Suppl. 4): 6-10.
14. Glanemann M, Eipel C, Nussler AK, Vollmar B, Neuhaus P. Hyperperfusion syndrome in small-for-size livers. Eur Surg Res 2005; 37: 335-41.
15. Schoen JM,Wang HH, Minuk GY, Lautt W.W. Shear stressinduced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide 2001; 5: 453-64.
16. Bergheim I, Luyendyk JP, Steele C, et al. Metformin prevents endotoxin-induced liver injury after partial hepatectomy. J Pharmacol Exp Ther 2006; 316: 1053-61.
17. Abo T, Kawamura T, Watanabe H. Physiological responses of extrathymic T cells in the liver. Immunol Rev 2000; 174: 135-49.
18. Tian Y, JochumW, Georgiev P, et al. Kupffer cell-dependent TNF-alpha signaling mediates injury in the arterialized small-for-size liver transplantation in the mouse. Proc Natl Acad Sci USA 2006; 103: 4598-603.
19. Tian Y, Rudiger HA, Jochum W, Clavien P.A. Comparison of arterialized and nonarterialized orthotopic liver transplantation in mice: prowess or relevant model? Transplantation 2002; 74: 1242-6.
20. Strey CW, Markiewski M, Mastellos D, et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003; 198: 913-23.
21. Ota S, Suzuki S, Sakaguchi T, et al. Significance of morphological alteration by portal vein branch ligation in endotoxin-induced liver injury after partial hepatectomy. Liver Int 2007; 27: 1076-85.
22. Kameoka N, Chijiiwa K, Saiki S, Tanaka M. Advantage of preoperative portal vein occlusion for hepatectomy that exceeds portal vein occluded lobes. Surgery 1998; 123: 545-53.
23. Tumanov AV, Koroleva EP, Christiansen PA, et al. T cellderived lymphotoxin regulates liver regeneration. Gastroenterology 2009; 136: 694.
24. Galun E, Axelrod J.H. The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim Biophys Acta 2002; 1592: 345-58.
25. Jin X, Zhang Z, Beer-Stolz D, Zimmers TA, Koniaris L.G. Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology 2007; 46: 802-12.
26. Schwabe RF, Seki E, Brenner D.A. Toll-like receptor signaling in the liver. Gastroenterology 2006; 130: 1886-900.
27. Minagawa M, Oya H, Yamamoto S, et al. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology 2000; 31: 907-15.
28. Sun R, Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology 2004; 127: 1525-39.
29. Ito H, Ando K, Nakayama T, et al. Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology 2003; 38: 1116-24.
30. Matsushita T, Ando K, Kimura K, et al. IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo. Int Immunol 1999; 11: 657-65.
31. Hines IN, Kremer M, Isayama F, et al. Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis. Hepatology 2007; 46: 229-41.
32. Huang W, Dong Z, Wei H, et al. Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice. Liver Int 2006; 26: 339-45.
33. Nakashima H, Inui T, Habu Y, et al. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy. Gastroenterology 2006; 131: 1573-83.